How antiviral pill molnupiravir shot ahead in the COVID drug hunt – Nature Related: What we know — and don’t know — about Merck’s new Covid-19 pill. [Press release – not published yet] Merck announces oral antiviral Molnupiravir reduced the risk of hospitalization or death by approximately 50 Percent compared to placebo for patients with […]

The post How antiviral pill Molnupiravir shot ahead in the COVID drug hunt. appeared first on Links Medicus.